bigrediska

MA 200 continues to serve as a reliable support.

Long
NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
2
We are at the lower boundary of the trend. Stoch sends a signal to buy. I think everything will end in complete correction yesterday's rise. In the end, is a pharmaceutical company. And now is the time to take the drugs.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.